CHRISTIAN HANSEN

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2023, CHRISTIAN HANSEN has already paid €1.03 in dividends. The last payout was in October 2023.

Financials

In the last year, CHRISTIAN HANSEN had revenue of €1.33bn and net profit of €227m

(EUR)	2023	YoY
Revenue	1.33bn	9.56%
Gross profit	723.3m	6.92%
Net profit	227m	0.84%
EBITDA	472.7m	15.15%

Fundamentals

Metric	Value
Market capitalization	€9.68bn
Number of shares	131.6m
52-week high/low	€76.29 - €55.88
Dividends	No
Beta	0.33
P/E ratio	42.75
PEG ratio	0.43
P/B ratio	5.11
P/S ratio	7.25

Company profile

Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. It operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry. The Health & Nutrition segment produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. It has a strategic collaboration with UPL Ltd. to develop and commercialize microbial-based bio solutions for sustainable agriculture. The company was founded in 1843 and is headquartered in Hørsholm, Denmark.

Name	CHRISTIAN HANSEN
CEO	Mauricio Graber
Headquarters	Horsholm, Denmark
Website	chr-hansen.com
Sector	Consumer Staples
Industry	Food Products
IPO	03/06/2010
Employees	3,834